(Q36458262)

14 August 2017

Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine (English)

1 reference

PMCID

351911

https://api.crossref.org/works/10.1128/AAC.11.1.21

14 August 2017

Therapy of Murine Aspergillosis with Amphotericin B in Combination with Rifampin or 5-Fluorocytosine (English)

1 reference

14 March 2023

0 references

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1128/AAC.11.1.21

14 March 2023

author name string

J. Arroyo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319750

14 March 2023

G. Medoff

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319750

14 March 2023

G. S. Kobayashi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319750

14 March 2023

language of work or name

English

0 references

publication date

1 January 1977

1 reference

PMCID

351911

full work available at URL

14 August 2017

https://europepmc.org/articles/PMC351911

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319750

https://europepmc.org/articles/PMC351911?pdf=render

14 March 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319750

https://journals.asm.org/doi/pdf/10.1128/AAC.11.1.21

14 March 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.11.1.21

Antimicrobial Agents and Chemotherapy

14 March 2023

published in

1 reference

14 August 2017

11

1 reference

14 August 2017

21-25

1 reference

14 August 2017

1

1 reference

Depression of phagocytosis by solutes in concentrations found in the kidney and urine

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=351911

Potentiation of the Antifungal Effects of Antibiotics by Amphotericin B

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=351911

Chemotherapeutic Activity of 5-Fluorocytosine and Amphotericin B Against Candida albicans in Mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=351911

Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=351911

Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=351911

Antimicrobial susceptibility testing of six clinical isolates of Aspergillus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=351911

Factors determining the susceptibility of mice to experimental phycomycosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=351911

Synergistic Action of Amphotericin B and 5-Fluorocytosine Against Yeast-Like Organisms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=351911

OCULAR PENETRATION OF AMPHOTERICIN B: A REPORT OF LABORATORY STUDIES AND A CASE REPORT OF POSTSURGICAL CEPHALOSPORIUM ENDOPHTHALMITIS.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=351911

The Combined Effect of 5-Fluorocytosine and Amphotericin B in the Therapy of Murine Cryptococcosis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=351911

Conditions for Immunosuppression by Rifampicin

21 September 2018

1 reference

12 December 2020

Amphotericin B Potentiation of Rifampicin as an Antifungal Agent against the Yeast Phase of Histoplasma capsulatum

1 reference

12 December 2020

Enhanced efficacy of amphotericin B and rifampicin combined in treatment of murine histoplasmosis and blastomycosis

1 reference

12 December 2020

Therapy of Cryptococcosis with a Combination of Flucytosine and Amphotericin B

1 reference

12 December 2020

A pharmacologic guide to the clinical use of amphotericin B

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.11.1.21

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

351911